The Hess Toy Truck, founded in NJ, is back with new mini collection
The 2025 Mini Collection, available now, features a limited production set of detailed, small-scale versions of holiday Hess Toy Trucks. It's sold exclusively at HessToyTruck.com for about $40, with free shipping and batteries included.
The collection has over 90 lights, 28 free-rolling wheels, articulating trailers, a pull-back racing motor, chrome accents, and detachable display bases with name plates – including the first red colored display base, a tribute to the "red velvet" Tanker.
Among the best-selling toys annually, the Hess Toy Truck is a collectible toy and a holiday tradition since 1964.
More: Yankees Manager Aaron Boone, Hess Toy Truck gift Children's Specialized patients
This year's set includes:
The Miniature 1995 Toy Truck and Helicopter, a flatbed tractor-trailer that doubles as a helicopter landing pad and helicopter with free spinning rotor.
The Miniature 1967 Tanker Truck "Red Velvet" Tribute Edition, which pays tribute to the 1967 "Red Velvet" Tanker with a red display base.
The Miniature 2016 Toy Truck and Dragster, a motorsport flatbed hauler with six free-rolling wheels and 40 lights and a top-fuel Dragster with pull-back motor.
Hess founder Leon Hess grew up in Asbury Park during the Great Depression. In 1933, after finishing high school and unable to afford college, the then-19-year old bought a second-hand 615-gallon oil delivery truck and started a business delivering fuel oil to homes in his hometown.
In 1964, four years after opening the first Hess branded gas station, Hess decided to offer families a toy for the holidays — the Hess Toy Truck.
Hess wanted a toy truck made with craftmanship and electronics, a concept that endures to this day. The first was a replica of the company's first B61 Mack truck and trailer and had working headlights, taillights controlled by a switch, and a cargo tank that could be filled and emptied with an accompanying funnel and rubber hose. The features were rare for toys of the time.
The annual holiday Hess Toy Truck will be released Oct. 20. More details will be announced later this year.
Also available is the My Plush Hess Truck: 2025 Farm Tractor. The squeeze-activated soft toy is the sixth in the plush series from Hess, recognized for its lights and sing-along songs. It's safe for kids of all ages and is available at HessToyTruck.com for about $40 with free standard shipping and batteries.
email: cmakin@gannettnj.com
Cheryl Makin is an award-winning feature, news and education reporter for MyCentralJersey.com, part of the USA Today Network. Contact: Cmakin@gannettnj.com or @CherylMakin. To get unlimited access, please subscribe or activate your digital account today.
This article originally appeared on MyCentralJersey.com: Hess Toy Truck, founded in Cranbury NJ, back with new collection
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
a few seconds ago
- Forbes
Quantify Or Be Overlooked: The Resume Mistake Costing You Interviews
Stand out among the rest of applicants with adding metrics in your resume It is no secret that we live in a data-driven world. However, when it comes to resumes, many overlook the power of numbers. While there can be many other reasons why your application is rejected, a qualifiable versus quantifiable resume could be a contributing factor. If you want your accomplishments to stand out and resonate with hiring managers, start thinking in metrics. Here's why leaving out numbers on your resume could be costing you interviews. Hiring Managers Will Not Grasp Your Impact Without Metrics The absence of metrics on a resume is rarely intentional. Even in data-heavy roles, we often fail to step back and evaluate our broader impact over time. For some positions, quantifying results can be especially challenging - whether due to complex workflows or a lack of visibility into how individual contributions impact the bigger picture. However, hiring managers do not have access into your daily tasks, nor do they need that level of detail. What they care about is measurable impact. Quantifying your impact means taking the time to step back and analyze how your responsibilities fit within the larger company. Think about: Reflecting on questions like these can help you surface your strengths and make a compelling case for the value you bring in your next role. What Matters To You Now May Not Matter In Your Next Company, And Vice-Versa The work we do often feels significant, especially in high-pressure or toxic workplace environments. But what one company or leader values may not be of importance in a different organization. Conversely, an achievement you consider minor could resonate deeply with a hiring manager elsewhere. Even business units at the same company, for internal transfers, will have distinct focus areas. As such, it is essential to quantify as much as possible on your resume. Think about the scale and scope of your work: How many people did you collaborate with? What was the size and duration of the project? Who saw the results of your efforts? These details help bring context and credibility to your accomplishments. For example, managing a team of five versus thirty requires different, but equally valuable, skill sets. A small, highly collaborative team may require more guidance than a larger group of independent contributors. The key is to communicate those distinctions clearly so your next employer can fully understand your impact. Extensive Resume Reading Time Is Not An Option For Recruiters A 2018 eye-tracking study by careers site Ladders, Inc. revealed that recruiters spend an average of just 7.4 seconds reviewing a resume. With hundreds of applications flooding in for a single job, time is not on your side. Write your resume with clarity, conciseness, and impact recognizing the short read-time of resumes. Neuroscience research emphasizes that our brains process words and numbers using different regions. Words are interpreted primarily by the brain's language centers in the left hemisphere, while numbers activate areas linked to numerical cognition and quantity processing. Basically, numbers grab a reader's attention in a different way. Use this to your advantage and interject metrics often when summarizing accomplishments. By weaving metrics into your resume, you help recruiters understand your value faster. Use concise bullet points that balance descriptive language with quantifiable results. The easier you make it to connect your skills to impact, the more likely you are to stand out. Resumes need to capture attention fast and the most effective way to do that is by clearly demonstrating your impact. Incorporating numbers throughout your resume adds clarity, credibility, and context to your accomplishments. Whether leading teams, optimizing processes, or delivering results, metrics translate your work into a language that hiring managers understand. By expertly quantifying your successes, you will stand out and be more likely to land more interviews.
Yahoo
29 minutes ago
- Yahoo
Hologic (HOLX) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Wednesday afternoon. Here's what investors should know. Hologic met analysts' revenue expectations last quarter, reporting revenues of $1.01 billion, down 1.2% year on year. It was a slower quarter for the company, with a slight miss of analysts' full-year EPS guidance estimates and full-year revenue guidance meeting analysts' expectations. Is Hologic a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Hologic's revenue to be flat year on year at $1.01 billion, slowing from the 2.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.05 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Hologic has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 0.9% on average. Looking at Hologic's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Hologic is up 2.8% during the same time and is heading into earnings with an average analyst price target of $69.93 (compared to the current share price of $66.99). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
29 minutes ago
- Yahoo
CONMED (CNMD) Q2 Earnings: What To Expect
Medical tech company CONMED (NYSE:CNMD) will be announcing earnings results this Wednesday after market close. Here's what to look for. CONMED beat analysts' revenue expectations by 2.6% last quarter, reporting revenues of $321.3 million, up 2.9% year on year. It was a very strong quarter for the company, with a solid beat of analysts' full-year EPS guidance estimates and an impressive beat of analysts' EPS estimates. Is CONMED a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting CONMED's revenue to grow 1.9% year on year to $338.3 million, slowing from the 4.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. CONMED has missed Wall Street's revenue estimates three times over the last two years. Looking at CONMED's peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Boston Scientific delivered year-on-year revenue growth of 22.8%, beating analysts' expectations by 3.4%, and Intuitive Surgical reported revenues up 21.4%, topping estimates by 3.7%. Boston Scientific traded up 2.9% following the results while Intuitive Surgical was down 1.9%. Read our full analysis of Boston Scientific's results here and Intuitive Surgical's results here. Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. CONMED is down 4% during the same time and is heading into earnings with an average analyst price target of $66.60 (compared to the current share price of $50.02). Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
